Mechanisms and Inhibitors of Apoptosis in Cardiovascular Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|18|1783-1793

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.18, 2011-06, pp. : 1783-1793

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential of Rho-Kinase Inhibitors in Cardiovascular Diseases

By Hirooka Yoshitaka   Shimokawa Hiroaki  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite

Matrix Metalloproteinase Inhibitors as Prospective Agents for the Prevention and Treatment of Cardiovascular and Neoplastic Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-02 ,pp. : 289-316

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of the Na+,K+-ATPase and its inhibitors in cardiovascular diseases

By Quadri L.   Ferrandi M.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 1, 1998-01 ,pp. : 39-52

Informa Healthcare

Access to resources Recommend Favorite

The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: a patent review

By Pinto Donald J P   Qiao Jennifer X   Knabb Robert M  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 6, 2012-06 ,pp. : 645-661

Informa Healthcare

Access to resources Recommend Favorite

Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases

By Danser A.H.J.   Schunkert H.  

European Journal of Pharmacology, Vol. 410, Iss. 2, 2000-12 ,pp. : 303-316

Elsevier

Access to resources Recommend Favorite